Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
45.98
+1.64 (3.70%)
Dec 11, 2025, 11:07 AM EST - Market open
Vera Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$67.67
Upside
+47.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $23 → $33 | Hold | Maintains | $23 → $33 | -28.23% | Dec 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $75 → $97 | Buy | Maintains | $75 → $97 | +110.96% | Dec 8, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $60 → $73 | Strong Buy | Maintains | $60 → $73 | +58.76% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $85 → $90 | Strong Buy | Maintains | $85 → $90 | +95.74% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +13.09% | Nov 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +4.39% | Oct 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $56 → $53 | Buy | Maintains | $56 → $53 | +15.27% | Aug 7, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +19.62% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $85 | Strong Buy | Maintains | $75 → $85 | +84.86% | Jun 2, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $60 → $55 | Buy | Maintains | $60 → $55 | +19.62% | May 12, 2025 |
| Wedbush | Wedbush | Hold Maintains $34 → $26 | Hold | Maintains | $34 → $26 | -43.45% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $107 → $100 | Buy | Maintains | $107 → $100 | +117.49% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +63.11% | May 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $77 → $71 | Buy | Maintains | $77 → $71 | +54.41% | Mar 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $59 → $61 | Strong Buy | Maintains | $59 → $61 | +32.67% | Feb 27, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.